Literature DB >> 25903169

Squamous cell dysplasia and carcinoma of the conjunctiva. A nationwide, retrospective, epidemiological study of Danish patients.

Ingvild Ramberg1, Steffen Heegaard1, Jan Ulrik Prause2, Nicolai Christian Sjö1, Peter Bjerre Toft1.   

Abstract

PURPOSE: To investigate the epidemiology of squamous cell dysplasia and carcinoma of the conjunctiva in Denmark.
METHODS: Review of the histopathological case reports at the Eye Pathology Institute (EPI), University of Copenhagen, and the National Danish Pathology Bank from 1980 to 2011. Information regarding distribution of age and sex, localization, earlier pathology, comorbidity and recurrence of the condition was registered. The Cause of Death Registry at Statens Serum Institut was used to obtain information regarding cause of death.
RESULTS: A total of 143 cases were identified. Ninety-five (61%) had epithelial dysplasia, 19 (13%) had carcinoma in situ, and 29 (20%) had squamous cell carcinoma. A significantly higher proportion of men were found. The median age at diagnosis was 65 years. The risk of recurrence was 10.0% [95% confidence interval (CI): 5.0-15.0] after 1 year and 17.2% (95% CI: 10.8-23.7) after 5 years. The lesions were most often localized to the corneal limbus. In our records, one patient had a lymph node metastasis and the disease necessitated enucleation in two patients. No patients had died from squamous cell carcinoma of the conjunctiva.
CONCLUSION: Overall, our data are in agreement with the results of previous studies in Northern, high-latitude countries. There is a low incidence rate; the lesions are predominantly seen in men in their seventh decade and localized to the corneal limbus. The risk of recurrence is high, and the benign lesions have potential to progress to frank carcinoma.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  OSSN; conjunctiva; conjunctival intra-epithelial neoplasia; epidemiology; recurrence

Mesh:

Year:  2015        PMID: 25903169     DOI: 10.1111/aos.12743

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

Review 2.  Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports.

Authors:  Peter S Fagerberg; Ingvild M S Ramberg; Peter B Toft
Journal:  Ocul Oncol Pathol       Date:  2021-01-11

3.  Clinicodemographic profile and treatment outcome in patients of ocular surface squamous neoplasia.

Authors:  Rachna Meel; Rebika Dhiman; Murugesan Vanathi; Neelam Pushker; Radhika Tandon; Saranya Devi
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

Review 4.  Update on pharmacotherapy for ocular surface squamous neoplasia.

Authors:  Ghada Al Bayyat; Dan Arreaza-Kaufman; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-12

5.  Treatment challenges associated with a superiorly located bulbar conjunctival mass-case report and review of the literature.

Authors:  Halah Bin Helayel; Rafah Fairaq; AlHatoon A Al Najashi; Mohammed AlMutlak
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-24

6.  Conjunctival Lesions: A 5-Year Basic Demographic Data and Clinicopathological Review in a Tertiary Eye Care Hospital.

Authors:  Hind M Alkatan; Khalid M Alshomar; Hala A Helmi; Wajda M Alhothali; Abdulaziz M Alshalan
Journal:  J Epidemiol Glob Health       Date:  2021-11-30

Review 7.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.